Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

The impact of the Patient Protection and Affordable Care Act on insurance coverage and cancer-directed treatment in HIV-infected patients with cancer in the United States.

Corrigan KL, Nogueira L, Yabroff KR, Lin CC, Han X, Chino JP, Coghill AE, Shiels M, Jemal A, Suneja G.

Cancer. 2019 Nov 11. doi: 10.1002/cncr.32563. [Epub ahead of print]

PMID:
31709523
2.

The Association between the Comprehensive Epstein-Barr Virus Serologic Profile and Endemic Burkitt Lymphoma.

Coghill AE, Proietti C, Liu Z, Krause L, Bethony J, Prokunina-Olsson L, Obajemu A, Nkrumah F, Biggar RJ, Bhatia K, Hildesheim A, Doolan DL, Mbulaiteye SM.

Cancer Epidemiol Biomarkers Prev. 2019 Oct 16. doi: 10.1158/1055-9965.EPI-19-0551. [Epub ahead of print]

PMID:
31619404
3.

Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma.

Liu Z, Jarrett RF, Hjalgrim H, Proietti C, Chang ET, Smedby KE, Yu KJ, Lake A, Troy S, McAulay KA, Pfeiffer RM, Adami HO, Glimelius B, Melbye M, Hildesheim A, Doolan DL, Coghill AE.

Int J Cancer. 2019 Oct 16. doi: 10.1002/ijc.32741. [Epub ahead of print]

PMID:
31618442
4.

Multilaboratory Assessment of Epstein-Barr Virus Serologic Assays: the Case for Standardization.

Liu Z, Yu KJ, Coghill AE, Brenner N, Cao SM, Chen CJ, Chen Y, Doolan DL, Hsu WL, Labo N, Middeldorp JM, Miley W, Simon J, Wang CP, Waterboer T, Whitby D, Xie SH, Ye W, Hildesheim A.

J Clin Microbiol. 2019 Oct 23;57(11). pii: e01107-19. doi: 10.1128/JCM.01107-19. Print 2019 Nov.

PMID:
31434722
5.

HIV Infection, Cancer Treatment Regimens, and Cancer Outcomes Among Elderly Adults in the United States.

Coghill AE, Suneja G, Rositch AF, Shiels MS, Engels EA.

JAMA Oncol. 2019 Aug 1. doi: 10.1001/jamaoncol.2019.1742. [Epub ahead of print]

PMID:
31369037
6.

Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma.

Yu G, Hsu WL, Coghill AE, Yu KJ, Wang CP, Lou PJ, Liu Z, Jones K, Vogt A, Wang M, Mbulaiteye SM, Chen HH, Boland J, Yeager M, Diehl SR, Chen CJ, Hildesheim A, Goldstein AM.

Sci Rep. 2019 Jul 9;9(1):9916. doi: 10.1038/s41598-019-46137-4.

7.

Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base.

Coghill AE, Han X, Suneja G, Lin CC, Jemal A, Shiels MS.

Cancer. 2019 Aug 15;125(16):2868-2876. doi: 10.1002/cncr.32158. Epub 2019 May 3.

PMID:
31050361
8.

Survival after a cancer diagnosis among solid organ transplant recipients in the United States.

D'Arcy ME, Coghill AE, Lynch CF, Koch LA, Li J, Pawlish KS, Morris CR, Rao C, Engels EA.

Cancer. 2019 Mar 15;125(6):933-942. doi: 10.1002/cncr.31782. Epub 2019 Jan 9.

PMID:
30624768
9.

Pathology Characterization and Detection of Human Papillomavirus Type 16 in Rectal Squamous Cell Carcinomas.

Coghill AE, Bellizzi AM, Lynch CF, Shiels MS, Selk FR, Gillison M, Hernandez BY, Chan OTM, Engels EA.

Clin Gastroenterol Hepatol. 2019 Sep;17(10):2129-2131. doi: 10.1016/j.cgh.2018.11.006. Epub 2018 Nov 15.

PMID:
30448596
10.

Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants.

Coghill AE, Hsu WL, Yang Q, Wang CP, Lou PJ, Yu KJ, Yu G, Diehl SR, Chen CJ, Goldstein AM, Hildesheim A.

J Gen Virol. 2018 Sep;99(9):1268-1273. doi: 10.1099/jgv.0.001115. Epub 2018 Jul 5.

11.

Evaluation of Total and IgA-Specific Antibody Targeting Epstein-Barr Virus Glycoprotein 350 and Nasopharyngeal Carcinoma Risk.

Coghill AE, Bu W, Hsu WL, Nguyen H, Yu KJ, Chien YC, Chen CJ, Cohen JI, Hildesheim A.

J Infect Dis. 2018 Aug 14;218(6):886-891. doi: 10.1093/infdis/jiy250.

12.

Disparities and Determinants of Cancer Treatment in Elderly Americans Living With Human Immunodeficiency Virus/AIDS.

Rositch AF, Jiang S, Coghill AE, Suneja G, Engels EA.

Clin Infect Dis. 2018 Nov 28;67(12):1904-1911. doi: 10.1093/cid/ciy373.

13.

Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States.

Coghill AE, Engels EA, Schymura MJ, Mahale P, Shiels MS.

J Natl Cancer Inst. 2018 Sep 1;110(9):959-966. doi: 10.1093/jnci/djy010.

14.

Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome.

Liu Z, Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Yu KJ, Lou PJ, Wang CP, Mulvenna J, Middeldorp JM, Bethony J, Chen CJ, Doolan DL, Hildesheim A.

J Infect Dis. 2018 May 25;217(12):1923-1931. doi: 10.1093/infdis/jiy122.

15.

Omega-3 decreases IL-6 levels in HIV and human herpesvirus-8 coinfected patients in Uganda.

Coghill AE, Schenk JM, Mahkoul Z, Orem J, Phipps W, Casper C.

AIDS. 2018 Feb 20;32(4):505-512. doi: 10.1097/QAD.0000000000001722.

16.

Cancer Risk in Older Persons Living With Human Immunodeficiency Virus Infection in the United States.

Mahale P, Engels EA, Coghill AE, Kahn AR, Shiels MS.

Clin Infect Dis. 2018 Jun 18;67(1):50-57. doi: 10.1093/cid/ciy012.

17.

Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan.

Coghill AE, Pfeiffer RM, Proietti C, Hsu WL, Chien YC, Lekieffre L, Krause L, Teng A, Pablo J, Yu KJ, Lou PJ, Wang CP, Liu Z, Chen CJ, Middeldorp J, Mulvenna J, Bethony J, Hildesheim A, Doolan DL.

Clin Cancer Res. 2018 Mar 15;24(6):1305-1314. doi: 10.1158/1078-0432.CCR-17-1929. Epub 2018 Jan 4.

18.

Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma.

Coghill AE, Wang CP, Verkuijilen SAWM, Yu KJ, Hsu WL, Middeldorp JM, Hildesheim A.

J Med Virol. 2018 Jan;90(1):191-195. doi: 10.1002/jmv.24918. Epub 2017 Sep 11.

PMID:
28833336
19.

Excess Mortality among HIV-Infected Individuals with Cancer in the United States.

Coghill AE, Pfeiffer RM, Shiels MS, Engels EA.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1027-1033. doi: 10.1158/1055-9965.EPI-16-0964. Epub 2017 Jun 15.

20.

Survival Deficit for HIV-Infected Lymphoma Patients in the National Cancer Database.

Coghill AE, Strickler HD.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):289-290. doi: 10.1158/1055-9965.EPI-17-0006. No abstract available.

21.

Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer.

Ferreira MP, Coghill AE, Chaves CB, Bergmann A, Thuler LC, Soares EA, Pfeiffer RM, Engels EA, Soares MA.

AIDS. 2017 Feb 20;31(4):523-531. doi: 10.1097/QAD.0000000000001367.

22.

Birth order and risk of nasopharyngeal carcinoma in multiplex families from Taiwan.

Liu Z, Coghill AE, Pfeiffer RM, Hsu WL, Lou PJ, Wang CP, Yu KJ, Niwa S, Brotzman M, Ye W, Chen CJ, Hildesheim A.

Int J Cancer. 2016 Dec 1;139(11):2467-73. doi: 10.1002/ijc.30390. Epub 2016 Aug 30.

23.

Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.

Yanik EL, Achenbach CJ, Gopal S, Coghill AE, Cole SR, Eron JJ, Moore RD, Mathews WC, Drozd DR, Hamdan A, Ballestas ME, Engels EA.

J Clin Oncol. 2016 Sep 20;34(27):3276-83. doi: 10.1200/JCO.2016.67.6999. Epub 2016 Aug 9.

24.

High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.

Coghill AE, Bu W, Nguyen H, Hsu WL, Yu KJ, Lou PJ, Wang CP, Chen CJ, Hildesheim A, Cohen JI.

Clin Cancer Res. 2016 Jul 15;22(14):3451-7. doi: 10.1158/1078-0432.CCR-15-2299. Epub 2016 Feb 26.

25.

Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort.

Coghill AE, Johnson LG, Berg D, Resler AJ, Leca N, Madeleine MM.

Am J Transplant. 2016 Feb;16(2):565-73. doi: 10.1111/ajt.13596.

26.

Reply to L. Dal Maso et al.

Coghill AE, Shiels MS, Suneja G, Engels EA.

J Clin Oncol. 2016 Feb 1;34(4):390-1. doi: 10.1200/JCO.2015.64.6026. Epub 2015 Nov 23. No abstract available.

PMID:
26598741
27.

Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?

Coghill AE, Shiels MS, Rycroft RK, Copeland G, Finch JL, Hakenewerth AM, Pawlish KS, Engels EA.

AIDS. 2016 Jan 2;30(1):105-12. doi: 10.1097/QAD.0000000000000873.

28.

Are cancer outcomes worse in the presence of HIV infection?

Coghill AE, Engels EA.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1165-6. doi: 10.1158/1055-9965.EPI-15-0454. No abstract available.

29.

Anal Cancer Incidence in the United States, 1977-2011: Distinct Patterns by Histology and Behavior.

Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS.

Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1548-56. doi: 10.1158/1055-9965.EPI-15-0044. Epub 2015 Jul 29.

30.

Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States.

Coghill AE, Shiels MS, Suneja G, Engels EA.

J Clin Oncol. 2015 Jul 20;33(21):2376-83. doi: 10.1200/JCO.2014.59.5967. Epub 2015 Jun 15.

31.

Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature.

Coghill AE, Hildesheim A.

Am J Epidemiol. 2014 Oct 1;180(7):687-95. doi: 10.1093/aje/kwu176. Epub 2014 Aug 28. Review.

32.

Epstein-Barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan.

Coghill AE, Hsu WL, Pfeiffer RM, Juwana H, Yu KJ, Lou PJ, Wang CP, Chen JY, Chen CJ, Middeldorp JM, Hildesheim A.

Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1213-9. doi: 10.1158/1055-9965.EPI-13-1262. Epub 2014 Apr 27.

33.

Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry.

Scherer D, Koepl LM, Poole EM, Balavarca Y, Xiao L, Baron JA, Hsu L, Coghill AE, Campbell PT, Kleinstein SE, Figueiredo JC, Lampe JW, Buck K, Potter JD, Kulmacz RJ, Jenkins MA, Hopper JL, Win AK, Newcomb PA, Ulrich CM, Makar KW.

Genes Chromosomes Cancer. 2014 Jul;53(7):568-78. doi: 10.1002/gcc.22167. Epub 2014 Mar 28.

34.

Contribution of HIV infection to mortality among cancer patients in Uganda.

Coghill AE, Newcomb PA, Madeleine MM, Richardson BA, Mutyaba I, Okuku F, Phipps W, Wabinga H, Orem J, Casper C.

AIDS. 2013 Nov 28;27(18):2933-42. doi: 10.1097/01.aids.0000433236.55937.cb.

35.

Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study.

Kraus S, Hummler S, Toriola AT, Poole EM, Scherer D, Kotzmann J, Makar KW, Kazanov D, Galazan L, Naumov I, Coghill AE, Duggan D, Gigic B, Arber N, Ulrich CM.

Pharmacogenet Genomics. 2013 Aug;23(8):428-437. doi: 10.1097/FPC.0b013e3283631784.

36.

Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women.

Passarelli MN, Phipps AI, Potter JD, Makar KW, Coghill AE, Wernli KJ, White E, Chan AT, Hutter CM, Peters U, Newcomb PA.

Cancer Res. 2013 Jan 15;73(2):767-75. doi: 10.1158/0008-5472.CAN-12-2484. Epub 2012 Nov 13.

37.

The association between NSAID use and colorectal cancer mortality: results from the women's health initiative.

Coghill AE, Phipps AI, Bavry AA, Wactawski-Wende J, Lane DS, LaCroix A, Newcomb PA.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1966-73. doi: 10.1158/1055-9965.EPI-12-0672. Epub 2012 Aug 29.

38.

BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics.

Phipps AI, Buchanan DD, Makar KW, Burnett-Hartman AN, Coghill AE, Passarelli MN, Baron JA, Ahnen DJ, Win AK, Potter JD, Newcomb PA.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1792-8. doi: 10.1158/1055-9965.EPI-12-0674. Epub 2012 Aug 16.

39.

Impact of colon cancer screening on family history phenotype.

Newcomb PA, Savu A, Phipps AI, Coghill AE, Yasui Y.

Epidemiology. 2012 Mar;23(2):308-10. doi: 10.1097/EDE.0b013e3182456caa.

40.

Genetic variation in inflammatory pathways is related to colorectal cancer survival.

Coghill AE, Newcomb PA, Poole EM, Hutter CM, Makar KW, Duggan D, Potter JD, Ulrich CM.

Clin Cancer Res. 2011 Nov 15;17(22):7139-47. doi: 10.1158/1078-0432.CCR-11-1134. Epub 2011 Oct 5.

41.

Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women.

Passarelli MN, Coghill AE, Hutter CM, Zheng Y, Makar KW, Potter JD, Newcomb PA.

Genes Chromosomes Cancer. 2011 Nov;50(11):875-86. doi: 10.1002/gcc.20913. Epub 2011 Aug 24.

42.

Risk factors for eclampsia: a population-based study in Washington State, 1987-2007.

Coghill AE, Hansen S, Littman AJ.

Am J Obstet Gynecol. 2011 Dec;205(6):553.e1-7. doi: 10.1016/j.ajog.2011.06.079. Epub 2011 Jun 29.

PMID:
21855842
43.

Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women.

Coghill AE, Newcomb PA, Chia VM, Zheng Y, Wernli KJ, Passarelli MN, Potter JD.

Br J Cancer. 2011 Mar 1;104(5):763-8. doi: 10.1038/sj.bjc.6606041. Epub 2011 Feb 8.

44.

Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.

Coghill AE, Newcomb PA, Campbell PT, Burnett-Hartman AN, Adams SV, Poole EM, Potter JD, Ulrich CM.

Gut. 2011 Apr;60(4):491-8. doi: 10.1136/gut.2010.221143. Epub 2010 Nov 4.

45.

Aspirin use, colorectal cancer survival, and loss to follow-up.

Coghill AE, Newcomb PA, Potter JD.

JAMA. 2009 Dec 16;302(23):2549; author reply 2549-50. doi: 10.1001/jama.2009.1824. No abstract available.

PMID:
20009049

Supplemental Content

Loading ...
Support Center